Compare · OPRX vs RELX
OPRX vs RELX
Side-by-side comparison of OptimizeRx Corporation (OPRX) and RELX PLC PLC (RELX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPRX and RELX operate in Real Estate (Real Estate), so they compete in similar markets.
- RELX is the larger of the two at $61.47B, about 489.6x OPRX ($125.5M).
- Over the past year, OPRX is down 47.9% and RELX is down 36.0% - RELX leads by 11.9 points.
- RELX has been more active in the news (3 items in the past 4 weeks vs 1 for OPRX).
- RELX has more recent analyst coverage (12 ratings vs 11 for OPRX).
- Company
- OptimizeRx Corporation
- RELX PLC PLC
- Price
- $6.71+0.75%
- $33.71-0.94%
- Market cap
- $125.5M
- $61.47B
- 1M return
- +27.08%
- +2.77%
- 1Y return
- -47.90%
- -35.96%
- Industry
- Real Estate
- Real Estate
- Exchange
- NASDAQ
- NYSE
- IPO
- 2015
- News (4w)
- 1
- 3
- Recent ratings
- 11
- 12
OptimizeRx Corporation
OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.
RELX PLC PLC
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Latest OPRX
- OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
- OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
- OptimizeRx Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Klema Cathy was granted 34,517 shares, increasing direct ownership by 160% to 56,137 units (SEC Form 4)
- Director Lang James Paul was granted 34,517 shares, increasing direct ownership by 9% to 433,837 units (SEC Form 4)
- Director Presti Mariyamma Varghese was granted 17,258 shares, increasing direct ownership by 132% to 30,318 units (SEC Form 4)
- Director Spangler Patrick D was granted 34,517 shares, increasing direct ownership by 78% to 78,732 units (SEC Form 4)
- Director Vos Ellen O'Connor was granted 34,517 shares, increasing direct ownership by 48% to 107,159 units (SEC Form 4)
- Director Wasson Gregory D was granted 34,517 shares, increasing direct ownership by 60% to 91,700 units (SEC Form 4)
- Director Presti Mariyamma Varghese was granted 13,060 shares (SEC Form 4)
Latest RELX
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- LexisNexis Risk Solutions Launches Current Carrier Commercial to Transform Policy Verification for U.S. Insurers
- SEC Form 6-K filed by RELX PLC PLC
- Goldman initiated coverage on RELX
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- Consumers Ready and Comfortable to Share their Medical Information Electronically for Easier Life Insurance Underwriting